首頁 > 市場調查報告書 > 製藥

癌症呼吸器

市場調查報告書

商品編碼

1786787

非小細胞肺癌(NSCLC)的全球市場，規模，佔有率，趨勢，產業分析報告:類別，不同治療，各流通管道，各地區 - 市場預測，2025年～2034年

Non-Small Cell Lung Cancer Market Size, Share, Trends, & Industry Analysis Report By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region - Market Forecast, 2025-2034

出版日期: 2025年07月01日 | 出版商:

Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據 Polaris Market Research 的最新研究，預計到 2034 年，非小細胞肺癌 (NSCLC) 市場規模將達到 1,298.8 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

非小細胞肺癌 (NSCLC) 佔全球肺癌病例的大多數，並正在推動精準腫瘤學的發展。生物標記檢測、標靶療法和免疫療法的日益普及正在重塑治療方法，而液體活檢和突變特異性藥物的創新則有助於實現早期診斷並改善療效。

市場成長主要得益於全球非小細胞肺癌 (NSCLC) 盛行率的上升、標靶治療和免疫療法的日益普及，以及伴隨診斷在支持個人化治療方案方面的日益普及。

非小細胞肺癌 (NSCLC) 市場報告重點

按類型劃分，腺癌因其高盛行率和對標靶治療方案的強烈反應，在 2024 年佔據了市場佔有率的主導地位。

按治療類型劃分，標靶治療在 2024 年佔據了市場主導地位，這得益於 EGFR、ALK 和 KRAS 抑制劑在臨床上的廣泛應用。

按分銷管道劃分，醫院藥房在 2024 年佔據了市場主導地位，因為醫院藥房可以集中獲取晚期癌症治療藥物並進行臨床監管。

受分子診斷的早期應用和對新型療法的監管支持的推動，到2024年，北美將佔據全球非小細胞肺癌 (NSCLC) 市場的大部分佔有率。

由於癌症發生率上升、醫療保健可及性的擴大以及對腫瘤學研究的投資增加，預計亞太地區在預測期內將以最快的複合年增長率增長。

全球主要市場參與者：羅氏控股公司、阿斯特捷利康公司、默克公司等。

市場概述
非小細胞肺癌(NSCLC)市場動態
- 促進因素和機會
  - 全球非小細胞肺癌 (NSCLC) 病例激增
  - 液體活檢和多重檢測的臨床應用日益增加平台
- 限制與課題
  - 先進診斷工具的高成本
PESTEL分析
非小細胞肺癌(NSCLC)市場趨勢
價值鏈分析

第5章全球非小細胞肺癌(NSCLC)市場:類別

主要調查結果
簡介
扁平表皮癌症
大細胞癌症
腺癌症
其他

第6章全球非小細胞肺癌(NSCLC)市場:不同治療

主要調查結果
簡介
化療
標靶治療
免疫療法
其他

第7章全球非小細胞肺癌(NSCLC)市場:各流通管道

主要調查結果
簡介
醫院藥局
藥妝店·零售藥局
線上藥局

第8章全球非小細胞肺癌(NSCLC)市場:各地區

主要調查結果
簡介
- 非小細胞肺癌(NSCLC)市場評估:各地區，2020年～2034年
北美
- 北美:類別，2020～2034年
- 北美:不同治療，2020～2034年
- 北美:各流通管道，2020～2034年
- 美國
- 加拿大
歐洲
- 歐洲:類別，2020～2034年
- 歐洲:不同治療，2020～2034年
- 歐洲:各流通管道，2020～2034年
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
- 其他歐洲
亞太地區
- 亞太地區:類別，2020～2034年
- 亞太地區:不同治療，2020～2034年
- 亞太地區:各流通管道，2020～2034年
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
- 澳洲
- 其他亞太地區
中東·非洲
- 中東·非洲:類別，2020～2034年
- 中東·非洲:不同治療，2020～2034年
- 中東·非洲:各流通管道，2020～2034年
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 其他中東·非洲
南美
- 南美:類別，2020-2034年
- 南美:不同治療，2020-2034年
- 南美:各流通管道，2020～2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美國家

第9章競爭情形

擴大和收購的分析
- 擴大
- 收購
聯盟/合作/協定/公開

第10章企業簡介

Amgen Inc.
AstraZeneca PLC
Beigene Ltd.
Bristol-Myers Squibb Company
Eli Lilly And Company
Exelixis Inc.
Johnson & Johnson
Merck & Co., Inc.
Mirati Therapeutics Inc.
Novartis AG
Pfizer Inc.
Roche Holding AG

簡介目錄圖表

Product Code: PM6101

The non-small cell lung cancer market size is expected to reach USD 129.88 Billion by 2034, according to a new study by Polaris Market Research. The report "Non-Small Cell Lung Cancer Market Share, Size, Trends, Industry Analysis Report: By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-small cell lung cancer (NSCLC) represents the majority of global lung cancer cases and is driving advances in precision oncology. Increasing use of biomarker testing, targeted therapies, and immunotherapies is reshaping treatment approaches, while innovations in liquid biopsy and mutation-specific drugs are enabling earlier diagnosis and better outcomes.

Market growth is primarily driven by the rising global incidence of NSCLC, increasing adoption of targeted and immune-based therapies and the growing availability of companion diagnostics that support personalized treatment plans.

Non-Small Cell Lung Cancer Market Report Highlights

Based on type, the adenocarcinoma segment dominated the market share in 2024, driven by its high prevalence and strong response to targeted therapy options.

In terms of treatment, the targeted therapy segment dominated the market in 2024, supported by the broad clinical use of EGFR, ALK, and KRAS inhibitors.

Based on distribution channel, the hospital pharmacy segment dominated the market in 2024, due to centralized access to advanced oncology drugs and clinical oversight.

North America accounted for the majority share in the global non-small cell lung cancer market in 2024, driven by early adoption of molecular diagnostics and regulatory support for novel therapies.

Asia Pacific is projected to grow at the fastest CAGR during the forecast period, owing to rising cancer incidence, expanding healthcare access, and growing investment in oncology research.

A few global key market players include Roche Holding AG, AstraZeneca PLC, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly And Company, Novartis AG, Johnson & Johnson, Amgen Inc., Beigene Ltd., Exelixis Inc., and Mirati Therapeutics Inc.

Polaris Market Research has segmented the market report on the basis of type, treatment, distribution channel, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Squamous Cell Carcinoma

Large Cell Carcinoma

Adenocarcinoma

Other Type

By Treatment Outlook (Revenue, USD Billion, 2020-2034)

Chemotherapy

Targeted Therapy

Immunotherapy

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Drug Store and Retail Pharmacy

Online Pharmacy

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Non-Small Cell Lung Cancer Market Insights

4.1. Non-Small Cell Lung Cancer Market - Market Snapshot
4.2. Non-Small Cell Lung Cancer Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rapidly Rising Cases of NSCLC Globally
  - 4.2.1.2. Increasing Clinical Adoption of Liquid Biopsies and Multiplexed Testing Platforms
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Costs Associated with Advanced Diagnostic Tools
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Non-Small Cell Lung Cancer Market Trends
4.6. Value Chain Analysis

5. Global Non-Small Cell Lung Cancer Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
5.3. Squamous Cell Carcinoma
- 5.3.1. Global Non-Small Cell Lung Cancer Market, by Squamous Cell Carcinoma, by Region, 2020-2034 (USD Billion)
5.4. Large Cell Carcinoma
- 5.4.1. Global Non-Small Cell Lung Cancer Market, by Large Cell Carcinoma, by Region, 2020-2034 (USD Billion)
5.5. Adenocarcinoma
- 5.5.1. Global Non-Small Cell Lung Cancer Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
5.6. Other Type
- 5.6.1. Global Non-Small Cell Lung Cancer Market, by Other Type, by Region, 2020-2034 (USD Billion)

6. Global Non-Small Cell Lung Cancer Market, by Treatment

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
6.3. Chemotherapy
- 6.3.1. Global Non-Small Cell Lung Cancer Market, by Chemotherapy, by Region, 2020-2034 (USD Billion)
6.4. Targeted Therapy
- 6.4.1. Global Non-Small Cell Lung Cancer Market, by Targeted Therapy, by Region, 2020-2034 (USD Billion)
6.5. Immunotherapy
- 6.5.1. Global Non-Small Cell Lung Cancer Market, by Immunotherapy, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global Non-Small Cell Lung Cancer Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Non-Small Cell Lung Cancer Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacy
- 7.3.1. Global Non-Small Cell Lung Cancer Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
7.4. Drug Store and Retail Pharmacy
- 7.4.1. Global Non-Small Cell Lung Cancer Market, by Drug Store and Retail Pharmacy, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacy
- 7.5.1. Global Non-Small Cell Lung Cancer Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Non-Small Cell Lung Cancer Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Non-Small Cell Lung Cancer Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Non-Small Cell Lung Cancer Market - North America
- 8.3.1. North America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.3.3. North America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Non-Small Cell Lung Cancer Market - U.S.
  - 8.3.4.1. U.S.: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Non-Small Cell Lung Cancer Market - Canada
  - 8.3.5.1. Canada: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Non-Small Cell Lung Cancer Market - Europe
- 8.4.1. Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.4.3. Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Non-Small Cell Lung Cancer Market - UK
  - 8.4.4.1. UK: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Non-Small Cell Lung Cancer Market - France
  - 8.4.5.1. France: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Non-Small Cell Lung Cancer Market - Germany
  - 8.4.6.1. Germany: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Non-Small Cell Lung Cancer Market - Italy
  - 8.4.7.1. Italy: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Non-Small Cell Lung Cancer Market - Spain
  - 8.4.8.1. Spain: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Non-Small Cell Lung Cancer Market - Netherlands
  - 8.4.9.1. Netherlands: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Non-Small Cell Lung Cancer Market - Russia
  - 8.4.10.1. Russia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Non-Small Cell Lung Cancer Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Non-Small Cell Lung Cancer Market - Asia Pacific
- 8.5.1. Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Non-Small Cell Lung Cancer Market - China
  - 8.5.4.1. China: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Non-Small Cell Lung Cancer Market - India
  - 8.5.5.1. India: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Non-Small Cell Lung Cancer Market - Malaysia
  - 8.5.6.1. Malaysia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Non-Small Cell Lung Cancer Market - Japan
  - 8.5.7.1. Japan: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Non-Small Cell Lung Cancer Market - Indonesia
  - 8.5.8.1. Indonesia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Non-Small Cell Lung Cancer Market - South Korea
  - 8.5.9.1. South Korea: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Non-Small Cell Lung Cancer Market - Australia
  - 8.5.10.1. Australia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Non-Small Cell Lung Cancer Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Non-Small Cell Lung Cancer Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Non-Small Cell Lung Cancer Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Non-Small Cell Lung Cancer Market - UAE
  - 8.6.5.1. UAE: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Non-Small Cell Lung Cancer Market - Israel
  - 8.6.6.1. Israel: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Non-Small Cell Lung Cancer Market - South Africa
  - 8.6.7.1. South Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Non-Small Cell Lung Cancer Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Non-Small Cell Lung Cancer Market - Latin America
- 8.7.1. Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Non-Small Cell Lung Cancer Market - Mexico
  - 8.7.4.1. Mexico: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Non-Small Cell Lung Cancer Market - Brazil
  - 8.7.5.1. Brazil: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Non-Small Cell Lung Cancer Market - Argentina
  - 8.7.6.1. Argentina: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Non-Small Cell Lung Cancer Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Amgen Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AstraZeneca PLC
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Beigene Ltd.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Bristol-Myers Squibb Company
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Eli Lilly And Company
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Exelixis Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Johnson & Johnson
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Merck & Co., Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Mirati Therapeutics Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Novartis AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Pfizer Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Roche Holding AG
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development

簡介目錄圖表

List of Tables:

Table 1 Global Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 2 Global Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 3 Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 4 North America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 5 North America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 6 North America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 7 U.S.: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 8 U.S.: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 9 U.S.: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 10 Canada: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 11 Canada: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 12 Canada: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 13 Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 14 Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 15 Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 16 UK: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 17 UK: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 18 UK: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 19 France: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 20 France: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 21 France: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 22 Germany: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 23 Germany: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 24 Germany: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 25 Italy: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 26 Italy: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 27 Italy: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 28 Spain: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 29 Spain: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 30 Spain: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 31 Netherlands: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 32 Netherlands: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 33 Netherlands: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 34 Russia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 35 Russia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 36 Russia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 43 China: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 44 China: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 45 China: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 46 India: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 47 India: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 48 India: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 49 Malaysia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 50 Malaysia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 51 Malaysia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 52 Japan: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 53 Japan: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 54 Japan: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 55 Indonesia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 56 Indonesia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 57 Indonesia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 58 South Korea: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 59 South Korea: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 60 South Korea: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 61 Australia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 62 Australia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 63 Australia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 73 UAE: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 74 UAE: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 75 UAE: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 76 Israel: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 77 Israel: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 78 Israel: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 79 South Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 80 South Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 81 South Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 85 Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 86 Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 87 Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 88 Mexico: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 89 Mexico: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 90 Mexico: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 91 Brazil: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 92 Brazil: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 93 Brazil: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 94 Argentina: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 95 Argentina: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 96 Argentina: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Non-Small Cell Lung Cancer Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Non-Small Cell Lung Cancer Market, by Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Treatment
Figure 9. Global Non-Small Cell Lung Cancer Market, by Treatment, 2024 & 2034 (USD Billion)
Figure 10. Market by Distribution Channel
Figure 11. Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2024 & 2034 (USD Billion)